Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors.

Cancer Genetics and Cytogenetics
Simone MartinelliMarco Tartaglia

Abstract

The PTPN11 gene encodes SHP-2, a widely expressed cytoplasmic protein tyrosine phosphatase functioning as a signaling transducer. Germ-line PTPN11 mutations cause Noonan syndrome (NS), a developmental disorder characterized by an increased risk of malignancies. Recently, a novel class of activating mutations in PTPN11 has been documented as a somatic event in a heterogeneous group of leukemias. Because of the relatively higher prevalence of certain solid tumors in children with NS and the positive modulatory function of SHP-2 in RAS signaling, a wider role for activating PTPN11 mutations in cancer has been hypothesized. Here, we screened a number of solid tumors, including those documented in NS or in which deregulated RAS signaling occurs at significant frequency, for PTPN11 mutations. No disease-associated mutation was identified in rhabdomyosarcoma (n = 13), neuroblastoma (n = 32), melanoma (n = 50), thyroid (n = 85), and colon (n = 48) tumors; a novel missense change, promoting an increased basal phosphatase activity of SHP-2, was observed in one glioma specimen. Our data document that deregulated SHP-2 function does not represent a major molecular event in pediatric and adult tumors, further supporting our previous evidenc...Continue Reading

References

Nov 1, 1995·Archives of Pediatrics & Adolescent Medicine·J L Cotton, R G Williams
Sep 1, 1995·Journal of Medical Genetics·S KhanA Fryer
Apr 1, 1997·Pediatric Radiology·B Lopez-MirandaM I Boechat
Mar 10, 1998·Cell·P HofS E Shoelson
Jul 6, 2000·Pediatric Radiology·R IjiriK Imaizumi
Jun 8, 2001·Genes & Development·E A MaherR A DePinho
Apr 1, 2003·Endocrine Pathology·Giovanni Tallini
Apr 8, 2003·Journal of Pediatric Hematology/oncology·Andreas JungOliver Ehrt
Jun 6, 2003·Oncogene·David Polsky, Carlos Cordon-Cardo
Jun 27, 2003·Trends in Biochemical Sciences·Benjamin G NeelLily Pao
Dec 3, 2003·Blood·Mignon L LohKevin M Shannon
Dec 17, 2003·Current Opinion in Hematology·Marco TartagliaMignon L Loh
Mar 11, 2004·British Journal of Haematology·M F JohanJ T Reilly
Jul 30, 2004·American Journal of Hematology·Fiona WatkinsJames S Wainscoat
Feb 16, 2005·American Journal of Medical Genetics. Part a·Johannes Hans M MerksRaoul C M Hennekam
Apr 22, 2005·British Journal of Haematology·Marco TartagliaAndrea Biondi
May 3, 2005·The Lancet Oncology·Jing Yuan Fang, Bruce C Richardson
Aug 2, 2005·European Journal of Medical Genetics·Marco Tartaglia, Bruce D Gelb
Aug 30, 2005·Annual Review of Genomics and Human Genetics·Marco Tartaglia, Bruce D Gelb
Jul 1, 2008·Annals of Hematology·Maria J CarnicerJosep F Nomdedeu

❮ Previous
Next ❯

Citations

Jan 1, 2013·Pediatric Surgery International·Raquel Domingo-FernandezIsabella Bray
Feb 21, 2008·Cancer Metastasis Reviews·Gordon ChanBenjamin G Neel
Apr 2, 2008·Current Oncology Reports·Taolin Yi, Daniel Lindner
Mar 17, 2011·European Journal of Human Genetics : EJHG·Marjolijn C J JongmansNicoline Hoogerbrugge
Jul 22, 2010·Molecular Syndromology·M TartagliaB D Gelb
Sep 10, 2011·Journal of Lipid Research·Mariana CookeFabiana Cornejo Maciel
Nov 26, 2009·Acta Neuropathologica·Anna C NavisWiljan J A J Hendriks
Oct 21, 2014·Future Medicinal Chemistry·Sam ButterworthAlastair J Barr
Dec 7, 2007·European Journal of Pediatrics·Helen FryssiraEmmanuel Kanavakis
Jul 23, 2009·Cancer Science·Takashi MatozakiHiroshi Ohnishi
Aug 15, 2009·Genes, Chromosomes & Cancer·Simone MartinelliCarlo Dominici
May 13, 2010·Genes, Chromosomes & Cancer·Marjolijn C J JongmansNicoline Hoogerbrugge
Jun 15, 2016·Seminars in Cell & Developmental Biology·Yoshihito KanoMichael Ohh
Dec 1, 2015·Nature Communications·Severa BundaMichael Ohh
Mar 23, 2017·American Journal of Medical Genetics. Part a·Aurore SiegfriedMarie-Bernadette Delisle
Aug 19, 2020·Diagnostics·Mariachiara LodiAngela Mastronuzzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.